BSE: 0 | NSE: MAITREYA | Hospital & Healthcare Services | Small Cap
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Maitreya Medicare Ltd is a below average quality company.
The key valuation ratios of Maitreya Medicare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Maitreya Medicare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'23 | Mar'24 | TTM | |
|---|---|---|---|
| ROCE % ⓘ | 31.5% | 18.8% | - |
| Value Creation Index ⓘ | 1.3 | 0.3 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||
| Sales ⓘ | 38.5 | 46.5 | 47 |
| Sales YoY Gr. | - | 20.9% | - |
| Adj EPS ⓘ | 8.4 | 4.7 | 4.7 |
| YoY Gr. | - | -44.6% | - |
| BVPS (₹) ⓘ | 17.7 | 36.7 | 36.7 |
| Adj Net Profit ⓘ | 4.2 | 3.2 | 3 |
| Cash Flow from Ops. ⓘ | 2.4 | -0.3 | - |
| Debt/CF from Ops. ⓘ | 2.4 | -15.7 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | 20.9% | ||||
| Adj EPS ⓘ | NA | NA | NA | -44.6% | ||||
| BVPSⓘ | NA | NA | NA | 107.2% | ||||
| Share Price | - | - | - | 169.6% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'23 | Mar'24 | TTM | |
|---|---|---|---|
| Return on Equity % ⓘ | 28.7 | 14.1 | 12.8 |
| Op. Profit Mgn % ⓘ | 18.6 | 13.2 | 12 |
| Net Profit Mgn % ⓘ | 10.8 | 6.8 | 6.8 |
| Debt to Equity ⓘ | 0.4 | 0.1 | - |
| Working Cap Days ⓘ | 0 | 137 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 40 | 0 |
No data to display
Return on Equity has declined versus last 3 years average to 12.80%
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at 9.14%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 4.7 | 4.7 |
| TTM Sales (₹ Cr.) | 46.5 | 47.8 |
| BVPS (₹.) ⓘ | 36.7 | 36.7 |
| Reserves (₹ Cr.) ⓘ | 18 | 18 |
| P/BV ⓘ | 8.95 | 8.96 |
| PE ⓘ | 70.16 | 70.20 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 0.00 / 0.00 |
| All Time Low / High (₹) | - / - |
| Market Cap (₹ Cr.) | 223 |
| Equity (₹ Cr.) | 6.8 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 40.5 |
| Pledged * | 0.00 | 0.00 |
| PARTICULARS | Mar'23 | Mar'24 |
|---|---|---|
| Sales | 38 | 47 |
| Operating Expenses ⓘ | 31 | 40 |
| Manufacturing Costs | 7 | 8 |
| Material Costs | 5 | 7 |
| Employee Cost | 5 | 5 |
| Other Costs ⓘ | 15 | 21 |
| Operating Profit ⓘ | 7 | 6 |
| Operating Profit Margin (%) | 18.6% | 13.2% |
| Other Income ⓘ | 1 | 0 |
| Interest ⓘ | 1 | 1 |
| Depreciation ⓘ | 1 | 1 |
| Exceptional Items ⓘ | 0 | 0 |
| Profit Before Tax ⓘ | 6 | 4 |
| Tax ⓘ | 2 | 1 |
| Profit After Tax | 4 | 3 |
| PAT Margin (%) | 10.9% | 6.8% |
| Adjusted EPS (₹) | 7.8 | 4.2 |
| Dividend Payout Ratio (%) | 0% | 0% |
| PARTICULARS | Mar'23 | Mar'24 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 15 | 30 | ||||||||
| Share Capital ⓘ | 11 | 12 | ||||||||
| Reserves ⓘ | 4 | 18 | ||||||||
| Minority Interest | 0 | 0 | ||||||||
| Debt | 6 | 4 | ||||||||
| Long Term Debt | 5 | 3 | ||||||||
| Short Term Debt | 1 | 1 | ||||||||
| Trade Payables | 4 | 2 | ||||||||
| Others Liabilities ⓘ | 4 | 4 | ||||||||
| Total Liabilities ⓘ | 28 | 41 | ||||||||
Fixed Assets | ||||||||||
| Gross Block | 15 | 16 | ||||||||
| Accumulated Depreciation | 4 | 5 | ||||||||
| Net Fixed Assetsⓘ | 12 | 11 | ||||||||
| CWIP ⓘ | 0 | 0 | ||||||||
| Investmentsⓘ | 1 | 3 | ||||||||
| Inventories | 1 | 0 | ||||||||
| Trade Receivables | 9 | 13 | ||||||||
| Cash Equivalents | 1 | 6 | ||||||||
| Others Assetsⓘ | 4 | 7 | ||||||||
| Total Assets ⓘ | 28 | 41 | ||||||||
| PARTICULARS | Mar'23 | Mar'24 |
|---|---|---|
| Cash Flow From Operating Activity ⓘ | 2 | 0 |
| PBT ⓘ | 6 | 4 |
| Adjustment ⓘ | 2 | 3 |
| Changes in Working Capital ⓘ | -5 | -6 |
| Tax Paid ⓘ | 0 | -2 |
| Cash Flow From Investing Activity ⓘ | 0 | -6 |
| Capex | 0 | -1 |
| Net Investments | 0 | -3 |
| Others ⓘ | 1 | -2 |
| Cash Flow From Financing Activityⓘ | -1 | 10 |
| Net Proceeds from Shares ⓘ | 0 | 13 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 |
| Interest Paid ⓘ | -1 | -1 |
| Dividend Paid ⓘ | 0 | 0 |
| Others ⓘ | -1 | -2 |
| Net Cash Flow ⓘ | 1 | 4 |
| PARTICULARS | Mar'23 | Mar'24 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 47.66 | 18.87 | ||||||||
| ROCE (%) | 31.45 | 18.75 | ||||||||
| Asset Turnover Ratio | 1.39 | 1.36 | ||||||||
| PAT to CFO Conversion(x) | 0.5 | 0 | Working Capital Days | |||||||
| Receivable Days | 88 | 88 | ||||||||
| Inventory Days | 8 | 5 | ||||||||
| Payable Days | 275 | 167 | ||||||||
The company was originally incorporated as ‘Maitreya Medicare Private Limited’ a private limited company under the Companies Act, 2013 at Surat Gujarat, pursuant to a certificate of incorporation dated March 28, 2019, issued by the Registrar of Companies, Central Registration Centre (CRC) (RoC). Thereafter, name of the Company was changed from ‘Maitreya Medicare Private Limited’ to ‘Maitreya Medicare Limited’, consequent to conversion of the Company from private to public company, pursuant to a special resolution passed by the shareholders of the Company on March 06, 2023, and a fresh certificate of incorporation consequent to change of name was issued by the RoC on March 30, 2023.
Maitreya Medicare (MML) is a Multi Superspeciality hospital incorporated in the year 2019 based out in Surat, Gujarat. The company provides multi disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care. The company strives to provide quality service to more patients and it has scope for additional patients and improved occupancy rates. The company strategically focuses on the southern Gujarat healthcare market where it has a strong understanding of regional nuances, customer culture and the mind set of medical professionals and where there is a growing need for quality and affordable healthcare services. Its hospital also has integrated diagnostic services and pharmacies that cater to its patients.
The company follow a ‘patient first’ ideology by creating the good infrastructure with thrust on service delievery to all its stake holders, be it patient, staff or doctors, technology and support to put patient-first and foremost and be futuristic and innovative in the delivery of healthcare services. Patients are the key stakeholders in the healthcare industry everything revolves around patients’ comfort, their convenience in all respects should always be maintained. Its hospital is located in densely populated micro market with a low presence of good-quality hospitals, which provides it an opportunity to offer its services to a larger population and help its patients with greater access and connectivity to healthcare services. Its hospital being a full service hospital, operates independently serving the healthcare needs of patients, right from diagnostics to surgery and rehabilitation. It focuses on promoting and maintaining a culture that encourages the retention and growth of its healthcare professionals also.
Business area of the company
The company offers a comprehensive range of healthcare services across many specialities and super specialities, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
Award and Accreditation
Major events
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
FREE Become a savvy and confident
stock investor.
Hurry, limited to the first 10 users today!
Download APP
